ArticleMultiple sclerosis and related disorders2022

Tixagevimab and Cilgavimab (Evusheld) boosts antibody levels to SARS-CoV-2 in patients with multiple sclerosis on b-cell depleters.

William L Conte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.